Diaz Allene M.
SEC Form 4 insider trading activity
Diaz Allene M. has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 9, 2026.
On the most recent filing, Diaz Allene M. is listed as Director at IONIS PHARMACEUTICALS INC. Inside the rolling window, Diaz Allene M. reported no open-market purchases and 2 open-market sales totaling $5.2M in IONS. The largest disclosed transaction in the window is a sale of 54,878 IONS shares on Mar 3, 2026, worth $4.4M.
Companies traded
Other insiders at IONS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Diaz Allene M. made?
Diaz Allene M. has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.
Which companies does Diaz Allene M. trade?
Diaz Allene M. has filed SEC Form 4 disclosures for 1 company, including IONS.
When was Diaz Allene M.'s most recent SEC Form 4 filing?
Diaz Allene M.'s most recent SEC Form 4 filing on Tracefour is dated Jul 9, 2026.
What is Diaz Allene M.'s total buy and sell value in the current window?
Inside the rolling retention window, Diaz Allene M. bought $0 and sold $5.2M based on SEC Form 4 filings.
What was Diaz Allene M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 54,878 IONS shares on 2026-03-03, worth $4.4M, per SEC Form 4 filings.